Question to the Cabinet Office:
To ask His Majesty's Government what plans they have to ensure that the estates of deceased people treated with blood products for haemophilia before 1991 can receive compensation for hepatitis C infection without a documented positive test result; and what their timetable is for making decisions in connection with this.
The Infected Blood Compensation Scheme compensates for infection and the impact of infection, and not pre-existing congenital conditions, including haemophilia or other bleeding disorders. Claims to the Scheme must be supported by evidence, which includes showing that the person claiming was likely to have been infected with a relevant infection, such as Hepatitis C. This does not, necessarily, need to include evidence of a positive test result. Where evidence is missing, IBCA will take into account all relevant information when coming to a decision. This might include the person’s treatment history or evidence of their symptoms.
While the Infected Blood Inquiry may have noted particular circumstances that are related to individuals with haemophilia who were infected with Hepatitis C, at no point does it suggest that such people should be treated differently in a compensation scheme, nor did it make further recommendations on this point in its Additional Report.